Evergreen Capital Management LLC Makes New Investment in Chemed Co. (NYSE:CHE)

Evergreen Capital Management LLC purchased a new position in shares of Chemed Co. (NYSE:CHE) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 14,397 shares of the company’s stock, valued at approximately $7,812,000. Evergreen Capital Management LLC owned about 0.10% of Chemed at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of CHE. Norges Bank acquired a new stake in shares of Chemed during the 4th quarter worth approximately $92,359,000. Corient Private Wealth LLC grew its stake in shares of Chemed by 7.9% during the 4th quarter. Corient Private Wealth LLC now owns 2,741 shares of the company’s stock worth $1,603,000 after purchasing an additional 200 shares during the period. Franklin Resources Inc. grew its stake in Chemed by 45.4% in the 4th quarter. Franklin Resources Inc. now owns 9,861 shares of the company’s stock valued at $5,766,000 after acquiring an additional 3,077 shares during the period. US Bancorp DE grew its stake in Chemed by 83.6% in the 4th quarter. US Bancorp DE now owns 9,236 shares of the company’s stock valued at $5,401,000 after acquiring an additional 4,205 shares during the period. Finally, AXS Investments LLC acquired a new stake in Chemed in the 4th quarter valued at $181,000. 95.85% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Chemed news, EVP Nicholas Michael Westfall sold 2,000 shares of Chemed stock in a transaction on Tuesday, July 30th. The shares were sold at an average price of $561.58, for a total transaction of $1,123,160.00. Following the sale, the executive vice president now owns 5,990 shares of the company’s stock, valued at approximately $3,363,864.20. The sale was disclosed in a filing with the SEC, which is available at the SEC website. In other news, EVP Nicholas Michael Westfall sold 2,000 shares of Chemed stock in a transaction on Tuesday, July 30th. The stock was sold at an average price of $561.58, for a total transaction of $1,123,160.00. Following the transaction, the executive vice president now owns 5,990 shares in the company, valued at approximately $3,363,864.20. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Andrea R. Lindell sold 831 shares of Chemed stock in a transaction on Friday, August 16th. The stock was sold at an average price of $571.51, for a total value of $474,924.81. Following the transaction, the director now owns 5,725 shares in the company, valued at approximately $3,271,894.75. The disclosure for this sale can be found here. Insiders have sold a total of 6,744 shares of company stock valued at $3,828,231 in the last 90 days. 3.32% of the stock is owned by insiders.

Chemed Stock Performance

Chemed stock opened at $582.06 on Monday. The company’s fifty day moving average price is $569.34 and its 200 day moving average price is $577.23. Chemed Co. has a 1 year low of $497.36 and a 1 year high of $654.62. The stock has a market capitalization of $8.81 billion, a P/E ratio of 31.33, a P/E/G ratio of 2.31 and a beta of 0.44.

Chemed (NYSE:CHE) last released its quarterly earnings results on Wednesday, July 24th. The company reported $5.47 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $5.59 by ($0.12). Chemed had a net margin of 12.88% and a return on equity of 29.21%. The company had revenue of $595.88 million during the quarter, compared to analyst estimates of $599.20 million. During the same period in the prior year, the business posted $4.71 EPS. Chemed’s revenue was up 7.6% compared to the same quarter last year. Sell-side analysts predict that Chemed Co. will post 21.77 EPS for the current year.

Chemed Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, August 30th. Shareholders of record on Monday, August 12th were paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 0.34%. The ex-dividend date of this dividend was Monday, August 12th. This is a boost from Chemed’s previous quarterly dividend of $0.40. Chemed’s payout ratio is 10.76%.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.